VTCN1 blocking peptide product blog
Tags: Blocking Peptide; VTCN1; VTCN1 blocking peptide;
The VTCN1 vtcn1 (Catalog #MBS153856) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s VTCN1 can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).VTCN1 peptide is used for blocking the activity of VTCN1 antibody (MBS153856). Researchers should empirically determine the suitability of the VTCN1 vtcn1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The VTCN1 vtcn1 product has the following accession number(s) (GI #99028881) (NCBI Accession #NP_078902) (Uniprot Accession #Q7Z7D3). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Species: Human
Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. The following patways have been known to be associated with this gene. VTCN1 also interacts with the following gene(s): BTLA, CTLA4, PDCD1. Bone, Embryonic Tissue, Kidney, Liver, Lung, Ovary, Pancreas, Placenta, Prostate, Uterus tissues are correlated with this protein. Adenocarcinoma, Encephalomyelitis, Autoimmune, Experimental, Endometrial Neoplasms, Fibrosis, Hyperglycemia, Inflammation, Necrosis, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Diseases are some of the diseases may be linked to VTCN1 Peptide.